Immix Biopharma, Inc. (IMMX) PT Raised to $26 at Mizuho
Tweet Send to a Friend
Mizuho analyst Graig Suvannavejh raised the price target on Immix Biopharma, Inc. (NASDAQ: IMMX) to $26.00 (from $15.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
